Other Barks & Bites, Friday, January 3: USPTO Names New CFO, CAFC Invalidates Zohydro ER Patent Claims, Ninth Circuit Says TTAB Proceedings Don’t Preclude District Court Case

This week in Other Barks & Bites: the Federal Circuit affirms a district court’s obviousness finding invalidating Persion Pharmaceutical’s liver pain treatment patent; Deputy Trademark Commissioner Meryl Hershkowitz is promoted to Acting Commissioner for Trademarks at the USPTO; Jay Hoffman will begin his new role as  Chief Financial Officer at the USPTO on January 6; the Copyright Royalty Board publishes a notice of inquiry on royalties for statutory licenses; the Ninth Circuit finds that TTAB cancellation proceedings don’t preclude claims of trademark infringement in district court; the creators of the children’s cartoon Peppa Pig score a copyright victory in Chinese courts; a New Jersey District Court finds that the SCOTUS decision in Impression Products doesn’t prevent trademark claims against resellers; Singapore announces a new chief for its international IP commercialization agency; and Tesla beats Wall Street expectations on fourth quarter car deliveries.

Full Article Available Here